• World Orphan Drug Congress USA 2017

     

    THE GLOBAL ORPHAN DRUG
    CONFERENCE AND EXPO

     

    19 - 21 April 2017

  • Bringing stakeholders from across the world together to spearhead orphan drug development

     

    APPLY TO SPEAK

  • The place to be for leaders in the rare disease community

    Hans Schikan, CEO, Prosensa Therapeutics Bv

  • Fostering partnerships and collaboration amongst industry, governments, payers, investors and patients

    DOWNLOAD PROSPECTUS

This is the largest global orphan drug industry event

CONFERENCE

Agenda at World Orphan Drug Congress USA

With keynotes, interactive discussions, workshops and roundtables, this event is designed to tackle the most important challenges facing the orphan drug and rare disease industry.

READ MORE

EXHIBITION

Exhibit at World Orphan Drug Congress USA

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

READ MORE

NETWORKING

Network at World Orphan Drug Congress USA

We offer a variety of networking opportunities from Speed Networking to 1-2-1 Partnering sessions to ensure that you meet as many other attendees as possible in 2 days.

READ MORE

 

Together with:

WHAT'S NEW IN 2017

 

In 2017 we're looking to the future...

What, for instance, happens when a global orphan drug biopharma goes into Korea, India and Brazil – places where generics is king?

Or how commercially acceptable is an even-higher priced, potentially one-time treatment gene therapy?

Is the regulatory and reimbursement pathway more or less the same as other orphan drugs?

 

Whats new at the World Orphan Drug Congress USA 2017

World Orphan Drug Congress USA 2017 will have a whole day seminar on these forward-looking environments:
 

NextGen Therapies
featuring Gene Therapy, Biosimilars, Immunotherapy and other up-and-coming biologics...

Alongside a separate whole-day session on Personalized Medicine.
 

 

FIND OUT MORE

The largest global orphan drug industry event

The World Orphan Drug Congress USA is a place where innovation and expertise is showcased, solutions are found and learning is done.

 

If you offer a solution or product in the orphan drug space, the World Orphan Drug Congress USA is definitely the right place to do this.

 

DOWNLOAD PROSPECTUS


 

2016 KEYNOTE SPEAKERS INCLUDED

 

  • Alison Bateman House at World Orphan Drug Congress USA 2016
    Alison Bateman House
    Professor
    N.Y.U. Langone Medical Center
    Mauricio Berdugo at World Orphan Drug Congress USA 2016
    Mauricio Berdugo
    Associate Director, Health Science Executive
    Boehringer Ingelheim
    Mr Max Bronstein at World Orphan Drug Congress USA 2016
    Mr Max Bronstein
    Senior Director, Public and Government Relations
    EveryLife Foundation for Rare Diseases
  • Mr Kyle Brown at World Orphan Drug Congress USA 2016
    Mr Kyle Brown
    Chief Executive Officer and Founder
    PatientCrossroads
    Mr Yann Le Cam at World Orphan Drug Congress USA 2016
    Mr Yann Le Cam
    Chief Executive Officer
    EURORDIS
    Art Caplan at World Orphan Drug Congress USA 2016
    Art Caplan
    Head, Division of Medical Ethics
    N.Y.U. Langone Medical Center
  • Daniel Donovan at World Orphan Drug Congress USA 2016
    Daniel Donovan
    Co-Founder and CEO
    onevoice
    Ms Kate Frantz at World Orphan Drug Congress USA 2016
    Ms Kate Frantz
    Awareness Program Manager
    International Pemphigus And Pemphigoid Foundation
    Ms Pat Furlong at World Orphan Drug Congress USA 2016
    Ms Pat Furlong
    Founding President and Chief Executive Officer
    Parent Project Muscular Dystrophy
  • Bruno Hatschbach at World Orphan Drug Congress USA 2016
    Bruno Hatschbach
    President
    National Association of Rare Diseases, Brazil
    Robert Haws at World Orphan Drug Congress USA 2016
    Robert Haws
    Pediatric Nephrologist
    Marshfield Clinic
    Samit Hirawat at World Orphan Drug Congress USA 2016
    Samit Hirawat
    Senior Vice President
    Novartis Oncology
  • Dr Emil Kakkis at World Orphan Drug Congress USA 2016
    Dr Emil Kakkis
    President/Founder
    EveryLife Foundation for Rare Diseases
    Virginia Kimonis at World Orphan Drug Congress USA 2016
    Virginia Kimonis
    Professor, Department of Pediatrics
    University of California Irvine School of Medicine
    Tomoko Kodama at World Orphan Drug Congress USA 2016
    Tomoko Kodama
    Invited Researcher, Department of International Health and Collaboration
    National Institute of Public Health Japan
  • Laurie Letvak at World Orphan Drug Congress USA 2016
    Laurie Letvak
    Head, Clinical Policy and Medical Ethics, Chief Medical Office
    Novartis Pharmaceutical Corporation
    Richard Moscicki at World Orphan Drug Congress USA 2016
    Richard Moscicki
    Deputy Director for Science Operations, CDER
    FDA
    Yukiko Nishimura at World Orphan Drug Congress USA 2016
    Yukiko Nishimura
    Chief Secretariat of International Relations
    Japan Patients Association, ASrid
  • Ian Phillips at World Orphan Drug Congress USA 2016
    Ian Phillips
    Director, Center for Rare Disease Therapies
    Keck Graduate Institute of Applied Life Sciences
    Mr Stephen Rose at World Orphan Drug Congress USA 2016
    Mr Stephen Rose
    Chief Research Officer
    Foundation Fighting Blindness
    Steven Ryder at World Orphan Drug Congress USA 2016
    Steven Ryder
    Senior Vice President, Chief Development Officer
    Alexion
  • Peter Saltonstall at World Orphan Drug Congress USA 2016
    Peter Saltonstall
    CEO
    National Organization For Rare Disorders
    Bruno Sepodes at World Orphan Drug Congress USA 2016
    Bruno Sepodes
    Chair, Committee for Orphan Medicinal Products (COMP)
    European Medicines Agency
    Nancy Silliman at World Orphan Drug Congress USA 2016
    Nancy Silliman
    VP, Biostats, Epidemiology, Data Management & Programming
    Alexion
  • Charles Stanley at World Orphan Drug Congress USA 2016
    Charles Stanley
    Medical Director, Congenital Hyperinsulinism Center
    Children's Hospital of Philadelphia
    Charles Stark at World Orphan Drug Congress USA 2016
    Charles Stark
    Senior VP, Research and Development
    Emmaus Life Sciences
    Keith Watts at World Orphan Drug Congress USA 2016
    Keith Watts
    Executive Vice President, Strategic Services at One-World
    Oneworld
  • Roham Zamanian at World Orphan Drug Congress USA 2016
    Roham Zamanian
    Associate Professor of Medicine, Director, Adult Pulmonary Hypertension Service
    Stanford University School of Medicine
    Mr Benoit Arnould at World Orphan Drug Congress USA 2016
    Mr Benoit Arnould
    Senior Director, Global, Patient-Centered Outcomes
    MAPI
    Adam Barak at World Orphan Drug Congress USA 2016
    Adam Barak
    Managing Director
    PPi Healthcare Consulting
  • Ms Laurie Burke at World Orphan Drug Congress USA 2016
    Ms Laurie Burke
    Founder
    LORA Group
    John Coster at World Orphan Drug Congress USA 2016
    John Coster
    Director, Division of Pharmacy
    Center for Medicare and Medicaid Services
    Eric Gemmen at World Orphan Drug Congress USA 2016
    Eric Gemmen
    Senior Director, Scientific Affairs, Biostatistics and Outcomes Research
    Quintiles
  • Gigi Hirsch at World Orphan Drug Congress USA 2016
    Gigi Hirsch
    Executive Director, NEWDIGS & CBI
    Massachusetts Institute of Technology
    Kevin Huang at World Orphan Drug Congress USA 2016
    Kevin Huang
    President
    Chinese Organization for Rare Disorders
    Diana Macdonell at World Orphan Drug Congress USA 2016
    Diana Macdonell
    former Head, Secretariat
    Pharmaceutical Benefits Advisory Committee
  • Malcolm MacKenzie at World Orphan Drug Congress USA 2016
    Malcolm MacKenzie
    SVP, Strategic Planning & Customer Insights
    Juice Pharma Worldwide
    Mr Francois Meyer at World Orphan Drug Congress USA 2016
    Mr Francois Meyer
    Advisor To The President
    Haute Autorite De Sante
    Jeff Myers at World Orphan Drug Congress USA 2016
    Jeff Myers
    CEO
    Medicaid Health Plans of America
  • Edmund Pezalla at World Orphan Drug Congress USA 2016
    Edmund Pezalla
    VP
    Aetna Pharmacy Management
    Mark Rothera at World Orphan Drug Congress USA 2016
    Mark Rothera
    Chief Commercial Officer
    PTC Therapeutics
    Joel Schindler, PhD at World Orphan Drug Congress USA 2016
    Joel Schindler, PhD
    Senior Vice President, Healthcare Insights
    MarketVision Research
  • Mr Scott Schliebner at World Orphan Drug Congress USA 2016
    Mr Scott Schliebner
    Vice President, Scientific Affairs
    Pra Health Sciences
    Mary Seideman at World Orphan Drug Congress USA 2016
    Mary Seideman
    Partner
    Arcus Medica
    Alvin Shih at World Orphan Drug Congress USA 2016
    Alvin Shih
    EVP, Head of R&D
    Retrophin
  • Deborah Sittig at World Orphan Drug Congress USA 2016
    Deborah Sittig
    President
    Soft Bones
    Ms Abbe Steel at World Orphan Drug Congress USA 2016
    Ms Abbe Steel
    CEO
    HealthiVibe
    Rumen Stefanov at World Orphan Drug Congress USA 2016
    Rumen Stefanov
    Director
    Bulgarian Association for Promotion of Education and Science
  • Michael Thomas at World Orphan Drug Congress USA 2016
    Michael Thomas
    Principal
    ZS Associates
    Sheela Upadhyaya at World Orphan Drug Congress USA 2016
    Sheela Upadhyaya
    Associate Director Highly Specialised Technologies, Centre for Health Technology Evaluation
    National Institute For Health and Care Excellence
    Steve Usdin at World Orphan Drug Congress USA 2016
    Steve Usdin
    Senior Editor
    BioCentury
  • Ms Elizabeth White at World Orphan Drug Congress USA 2016
    Ms Elizabeth White
    AVP, Rare Disease Commercial Development
    Pfizer
    Rashmi Gopal-Srivastava at World Orphan Drug Congress USA 2016
    Rashmi Gopal-Srivastava
    Director, Extramural Research Program, Office Rare Diseases Research, National Cnter for Advancing Translational Sciences(NCATS)
    National Institutes of Health
    Andrea Gropman at World Orphan Drug Congress USA 2016
    Andrea Gropman
    professor
    Children's National Medical Center
  • Mrs. Claudia Hirawat at World Orphan Drug Congress USA 2016
    Mrs. Claudia Hirawat
    Chair
    EURORDIS
    Frederick Kaskel at World Orphan Drug Congress USA 2016
    Frederick Kaskel
    Professor of Pediatrics
    Albert Einstein College of Medicine
    Dr Charles O'Neill at World Orphan Drug Congress USA 2016
    Dr Charles O'Neill
    Vice President, Pharmacological Sciences
    BioMarin
  • Carmencita Padilla at World Orphan Drug Congress USA 2016
    Carmencita Padilla
    Chancellor, University of the Philippines, Chair
    Philippine Society for Orphan Disorders
    Colin Hayward at World Orphan Drug Congress USA 2016
    Colin Hayward
    Chief Medical Officer
    Premier Research
    Juliet Moritz at World Orphan Drug Congress USA 2016
    Juliet Moritz
    Executive Director, Strategic Development, Rare Diseases
    Premier Research
  • Michael Murphy at World Orphan Drug Congress USA 2016
    Michael Murphy
    Chief Medical & Scientific Officer
    Worldwide Clinical Trials
    Kate Perry at World Orphan Drug Congress USA 2016
    Kate Perry
    Director of Behavioral Science
    Atlantis Healthcare
    Mark Sorrentino at World Orphan Drug Congress USA 2016
    Mark Sorrentino
    Executive Medical Director, Global Product Development
    PPD
  • Carlo Tomino at World Orphan Drug Congress USA 2016
    Carlo Tomino
    Research and Development Coordinator, San Raffaele Institute of Reseach, Rome (Former Head of Research and Clinical Trials
    Italian Medicines Agency AIFA
    Tara Grabowsky at World Orphan Drug Congress USA 2016
    Tara Grabowsky
    Chief Medical Officer
    Vencore
    Oodaye Shukla at World Orphan Drug Congress USA 2016
    Oodaye Shukla
    Sr. Data Scientist
    Vencore
  • Scott Gray at World Orphan Drug Congress USA 2016
    Scott Gray
    CEO
    Clincierge
    Magnus Corfitzen at World Orphan Drug Congress USA 2016
    Magnus Corfitzen
    CEO
    CMC Contrast AB
    Colin Foster at World Orphan Drug Congress USA 2016
    Colin Foster
    President and CEO
    BioBlast Pharma
  • Lewis Gruber at World Orphan Drug Congress USA 2016
    Lewis Gruber
    Chief Executive Officer
    SIWA Regenerative Medicine
    Dr Harvey Kupferberg at World Orphan Drug Congress USA 2016
    Dr Harvey Kupferberg
    Executive Consultant
    Biopharm Solutions
    Antonio Lee at World Orphan Drug Congress USA 2016
    Antonio Lee
    Chief Executive Officer & Managing Director
    MEDIPOST America
  • Thomas Miller at World Orphan Drug Congress USA 2016
    Thomas Miller
    CEO
    Therabron Therapeutics
    Antoun Nabhan at World Orphan Drug Congress USA 2016
    Antoun Nabhan
    Vice President, Corporate Development
    Raptor Pharmaceuticals
    Mr Kim Arvid Nielsen at World Orphan Drug Congress USA 2016
    Mr Kim Arvid Nielsen
    Chief Executive Officer
    Serendex Pharmaceuticals
  • Mr Jean Nordstrom at World Orphan Drug Congress USA 2016
    Mr Jean Nordstrom
    Chairman & CEO
    Sixera Pharma Ab
    Agnes Rafalko at World Orphan Drug Congress USA 2016
    Agnes Rafalko
    Founder and CEO
    Glycomine
    Stanley Satz at World Orphan Drug Congress USA 2016
    Stanley Satz
    Chief Scientific Officer
    Advanced Imaging Projects
  • Sunanda Singh at World Orphan Drug Congress USA 2016
    Sunanda Singh
    Founder & CEO
    Singh Biotechnology
    Ms Tina Verolin at World Orphan Drug Congress USA 2016
    Ms Tina Verolin
    Program Director
    Toleranzia AB
    Martin Welschof at World Orphan Drug Congress USA 2016
    Martin Welschof
    Chief Executive Officer
    Opsona Theraeputics
  • Marc Wolff at World Orphan Drug Congress USA 2016
    Marc Wolff
    EVP & CFO
    Sancilio Pharmaceuticals Company
    May Orfali at World Orphan Drug Congress USA 2016
    May Orfali
    Medicines Development Lead- Rare Diseases
    Pfizer
    Faridah Aryani at World Orphan Drug Congress USA 2016
    Faridah Aryani
    Deputy Director
    Pharmaceutical Services Division Ministry of Health Malaysia
  • Dr Frank Sciavolino at World Orphan Drug Congress USA 2016
    Dr Frank Sciavolino
    President and Chief Scientific Officer
    Thetis Pharmaceuticals
    David Young at World Orphan Drug Congress USA 2016
    David Young
    CEO
    Promet Therapeutics
    Angela Patricia Chaves Restrepo at World Orphan Drug Congress USA 2016
    Angela Patricia Chaves Restrepo
    President
    Colombian Federation for Rare Diseases
  • Mr Richard Chipkin at World Orphan Drug Congress USA 2016
    Mr Richard Chipkin
    President and Chief Executive Officer
    Psyadon Pharmaceuticals
    William Daly at World Orphan Drug Congress USA 2016
    William Daly
    Chief Executive Officer
    Heart Metabolics
    Arthur Klausner at World Orphan Drug Congress USA 2016
    Arthur Klausner
    Chief Executive Officer
    Gem Pharmaceuticals
  • Ms Albena Patroneva at World Orphan Drug Congress USA 2016
    Ms Albena Patroneva
    Chief Medical Officer
    Marinus Pharmaceuticals
    Dr Gayatri Rao at World Orphan Drug Congress USA 2016
    Dr Gayatri Rao
    Director, Orphan Products Development
    FDA
    Dr Yaffa Rubinstein at World Orphan Drug Congress USA 2016
    Dr Yaffa Rubinstein
    Program Director, Office for Rare Diseases Research, National Center for Advancing Translational Sciences,
    National Institutes of Health
  • Evan Unger at World Orphan Drug Congress USA 2016
    Evan Unger
    Chief Executive Officer
    Nuvox Pharma
    Eric Olson at World Orphan Drug Congress USA 2016
    Eric Olson
    Senior Director, Corporate Development
    AGTC
    Trey Putnam at World Orphan Drug Congress USA 2016
    Trey Putnam
    VP GM, Regulatory Sciences
    Cardinal Health
  • Mark Vineis at World Orphan Drug Congress USA 2016
    Mark Vineis
    VP, Specialty Pharmacy
    Cardinal Health
    Leone Atkinson at World Orphan Drug Congress USA 2016
    Leone Atkinson
    Sen Med Dir
    Covance
    Ms Stella Blackburn at World Orphan Drug Congress USA 2016
    Ms Stella Blackburn
    Vice President, Global Head of Risk Management, Real-World & Late Phase Research
    Quintiles
  • Fumihiko Urano at World Orphan Drug Congress USA 2016
    Fumihiko Urano
    Samuel E. Schechter Professor of Medicine
    University of Washington School of Medicine
    Jessica Armstrong at World Orphan Drug Congress USA 2016
    Jessica Armstrong
    Senior Manager, Early Diagnosis Campaign
    Pulmonary Hypertension Association
    Gerald Commissiong at World Orphan Drug Congress USA 2016
    Gerald Commissiong
    President and Chief Executive Officer
    Amarantus Therapeutics
  • William Howard at World Orphan Drug Congress USA 2016
    William Howard
    President and Chief Executive Officer
    Alitair Pharmaceuticals
    Daniel Leszkiewicz at World Orphan Drug Congress USA 2016
    Daniel Leszkiewicz
    Senior Vice President, Health Sciences & Applied Analytics
    81qd
    Kelly Myers at World Orphan Drug Congress USA 2016
    Kelly Myers
    Executive VP, Data Analytics
    81qd
  • Thomas Sproat at World Orphan Drug Congress USA 2016
    Thomas Sproat
    Senior Vice President, Scientific Services
    ClinicalMind
    Pedro Carlos Stelian at World Orphan Drug Congress USA 2016
    Pedro Carlos Stelian
    Full Member of the National Research Ethical Board (CONEP), President
    National Association of Patients of Gaucher Disease and other Rare Diseases, Brazil
    Ellen Welch at World Orphan Drug Congress USA 2016
    Ellen Welch
    Vice President of Biology and Genetic Disorders
    PTC Therapeutics
  • Isabelle Lousada at World Orphan Drug Congress USA 2016
    Isabelle Lousada
    CEO
    The Amyloidosis Research Consortium
    Mr Marshall Summar at World Orphan Drug Congress USA 2016
    Mr Marshall Summar
    Division Chief of Genetics and Metabolism
    Children's National Medical Center
    Chris Kavlick at World Orphan Drug Congress USA 2016
    Chris Kavlick
    Director Sales, Regulatory Sciences
    Cardinal Health
  • Jan Nielsen at World Orphan Drug Congress USA 2016
    Jan Nielsen
    VP, Sonexus Access and Patient Support
    Cardinal Health
    Trish Caruana at World Orphan Drug Congress USA 2016
    Trish Caruana
    President/CEO
    CurePSP
    Birgit Anderegg at World Orphan Drug Congress USA 2016
    Birgit Anderegg
    Acting VP Business Development
    Prana Biotechnology
  • Jim DeMesa at World Orphan Drug Congress USA 2016
    Jim DeMesa
    Chief Executive Officer
    Integene International
    Marc Hedrick at World Orphan Drug Congress USA 2016
    Marc Hedrick
    President and CEO
    Cytori Therapeutics
    Taneli Jouhikainen at World Orphan Drug Congress USA 2016
    Taneli Jouhikainen
    Chief Operating Officer
    Savara Pharmaceuticals
  • Derek Kelaita at World Orphan Drug Congress USA 2016
    Derek Kelaita
    VP, Business Development
    ArmaGen Technologies
    David Lowe at World Orphan Drug Congress USA 2016
    David Lowe
    CEO
    Aeglea Biotherapeutics
    Mr Steven Peltier at World Orphan Drug Congress USA 2016
    Mr Steven Peltier
    VP, Regulatory and Quality Compliance
    Recordati Rare Diseases
  • Cynthia Schwalm at World Orphan Drug Congress USA 2016
    Cynthia Schwalm
    President & CEO
    Ipsen Biopharmaceuticals North America
    Mr Ross Silver at World Orphan Drug Congress USA 2016
    Mr Ross Silver
    Principal Analyst
    Vista Partners
    Stephen Groft at World Orphan Drug Congress USA 2016
    Stephen Groft
    Senior Advisor to the Director, NCATS
    N.I.H

 

SEE ALL 2016 SPEAKERS

WHO ATTENDS?

Here's a glimpse of who attends World Orphan Drug Congress USA

 

AccessPharmaCon,LLC Aegerion Pharmaceuticals  Aetna Pharmacy Management  Alexion Pharmaceuticals  Andarix Pharmaceuticals  ArmaGen Technologies, Inc.  Ashfield Healthcare   Asklepion Pharmaceuticals LLC  Ax-S Pharma  B.D.C. Venture Capital  BioBlast Pharma Ltd  Biomarin Pharmaceutical Inc.  BioPontis Alliance for Rare Disease Brace Pharma Capital   Brazilian Federal Council of Medicine  Bristol-Myers Squibb  CatalentPharma Solutions   CatalystPharmaceutical Partners  CDER FDA  Clear Pharma  Clementia Pharmaceuticals Inc.   Clinuvel Pharmaceuticals Ltd  Dicerna Pharmaceuticals  DrugDev  EvaluatePharma Ltd   Genoa Pharmaceuticals   Genpharm  GenSight Biologics  Genzyme Corp  Giddi Pharma Co., Ltd.   Idera Pharmeceuticals  IDIS Pharma   Iptechex Pharmalicensing  Jazz Pharmaceuticals, Inc  Juice Pharma Worldwide   KBI Biopharma Inc   Lumos Pharma   M3 Pharma  Marathon Pharmaceuticals LLC   Marinus Pharmaceuticals  Momenta Pharmaceuticals Inc  Opsona Therapeutics Ltd  Optio Biopharma Solutions LLC  Orpharma  Pfizer, Inc  Pharmaceutics International In  Pharmaessentia Corp   Pharnext   Portola Pharmaceuticals , Inc.  Provectus PharmaceuticalsInc   QuayPharma  Quintiles Inc  Raptor Pharmaceuticals Corp  Reata Pharmaceuticals   Recordati S.p.A  Recursion Pharmaceuticals  Retrophin   Sanofi   Savara Pharmaceuticals  Seattle Children's Research Institute   Shire Pharmaceuticals Inc  Taiba Pharma LLC Teva  Threshold Pharmaceuticals Inc   Tolero Pharmaceuticals   Ultragenyx Pharmaceutical Inc.  Valley Fever Solutions   Vanda Pharmaceuticals Inc   Vertex Pharmaceuticals 

 

FIND OUT MORE

 

OUR SPONSORS & EXHIBITORS

 

  • Platinum Sponsor

    Premier Research at World Orphan Drug Congress USA 2017

    Gold Sponsor

    AmerisourceBergen at World Orphan Drug Congress USA 2017
  • Silver Sponsor

    Clincierge at World Orphan Drug Congress USA 2017

    Silver Sponsor

    onevoice at World Orphan Drug Congress USA 2017
  • Silver Sponsor

    PRA Health Sciences at World Orphan Drug Congress USA 2017

    Silver Sponsor

    Quintiles at World Orphan Drug Congress USA 2017
  • Bronze Sponsor

    Lapidus Data at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    Medicom Innovation Partner a/s at World Orphan Drug Congress USA 2017
  • Bronze Sponsor

    MME at World Orphan Drug Congress USA 2017

    Exhibitor

    AnovaFill at World Orphan Drug Congress USA 2017
  • Exhibitor

    APL at World Orphan Drug Congress USA 2017

    Exhibitor

    Clinart MENA at World Orphan Drug Congress USA 2017
  • Exhibitor

    CORAM Clinical Trials at World Orphan Drug Congress USA 2017

    Exhibitor

    Illingworth Research Ltd at World Orphan Drug Congress USA 2017
  • Exhibitor

    INC Research at World Orphan Drug Congress USA 2017

    Exhibitor

    Pharmaceutics International at World Orphan Drug Congress USA 2017
  • Exhibitor

    PSR-Agility at World Orphan Drug Congress USA 2017
 

JOIN THEM

Get Involved

Your customers are here continuously looking for new strategies and technologies to expedite orphan drugs to patients.

 

If you offer a solution or product in the orphan drug space, then you need to be here

 

DOWNLOAD PROSPECTUS